I have two collaborations.
One is with Syngenta, the Canadian subsidiary of Syngenta, but really it's through North Carolina. They're supporting some of our research and some of my collaborators' research, and there's considerable cash on the table with Syngenta.
To me, the more exciting partnership—I guess I'll put this on the record—is with Novozymes, which is a Danish company. We've been in talks with them for two years to support our microbial work in using microbes that can biologically convert atmospheric gas into ammonia, rather than using oil and natural gas. Because it's the Canadian subsidiary of the Danish company, they're reluctant to put cash on the table, as my colleague Rick Yada said. They're happy to put a million dollars in kind, but putting $100,000 in real cash is tough.